UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 15, 2007
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
1-15525 |
|
36-4316614 |
|
(State or other
jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
One Edwards Way, Irvine, California |
|
92614 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
(949) 250-2500
Registrant’s telephone number, including area code
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On February 15, 2007, the Board of Directors of Edwards Lifesciences Corporation (the “Company”) amended the Company’s Bylaws to authorize the issuance of uncertificated shares. The Bylaws continue to authorize the issuance of certificated shares.
A copy of the Bylaws is attached as Exhibit 3.2.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
3.2 Amended and Restated Bylaws of Edwards Lifesciences Corporation.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: February 21, 2007 |
|
||
|
|
|
||
|
|
|
||
|
|
EDWARDS LIFESCIENCES CORPORATION |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Jay P. Wertheim |
|
|
|
|
Jay P. Wertheim |
|
|
|
|
Vice President, Associate General Counsel |
|
|
|
|
and Secretary |
|
3
Exhibit Index
|
Exhibit |
|
Description |
|
|
|
|
|
3.2 |
|
Amended and Restated Bylaws of Edwards Lifesciences Corporation. |
4